MoneyWorks4Me

IPCA Laboratories informs about analyst meet outcome

19 Aug 2024 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, IPCA Laboratories has enclosed transcript of Conference Call which was held on Wednesday, 14th August, 2024 to discuss the Company’s Q1FY25 earnings and business update.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..